This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Community News - February 27, 2020
Share |
Today’s spotlight shines on Francis Poulin, Director, Analytical Development at Sanofi.

Member Spotlight: Francis Poulin, Director, Analytical Development at Sanofi

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on Francis Poulin, Director, Analytical Development at Sanofi.

Q. What was your motivation to volunteer with CASSS?
My first CASSS meeting was WCBP 2016, when DC ended up under 20 inches of snow after the “Snowzilla” blizzard. I was born and raised in Québec, so I did not think anything of going to the meeting until I stepped out of Reagan National Airport and realized the city had ground to a halt. Several attendees ended up being delayed or could not make it to the symposium. Despite the disruption, Karen, the CASSS staff and the committee members who did make it rose up to the challenge and held a successful event. As I witnessed this unfold, I knew immediately that this was an organization I wanted to be a part of, and I volunteered to be on the scientific committee at the first opportunity a few weeks later.

Q. What would people be surprised to know about you?
I am Canadian and I never learned to play hockey, even though my dad was a Pee Wee hockey coach in my hometown.

Read More
Learn More

Save the Date for CMC Strategy Forum Summer

Phase Appropriate GMPs and CMC Considerations for Expedited Program Development

The purpose of this Forum is to understand the "acceptable" approaches to Phase-appropriate GMS and what would be the minimal requirements for Phase I vs. Phase II vs. Phase III GMPs. Topics will include: evolution of Quality Systems, raw materials, testing, equipment, software and production qualification vs. validation.

CMC Strategy Forum Japan Presentation Slides Available

Thank you to everyone that participated. The speaker slides are now available. We look forward to seeing you all again next year!

Download Slides

Use Your CASSS Login to Make Submissions Online

Submitting an abstract for a talk, technical seminar, poster or roundtable discussion?  Use your CASSS login – same user name and password. Can’t remember your username or password?  Click below or call the CASSS office for assistance at 510.428.0740

Reset Username/Password






more Calendar

9/14/2020 » 9/17/2020
Mass Spec 2020

9/28/2020 » 10/1/2020
CE Pharm 2020

Membership Software Powered by YourMembership  ::  Legal